HIV-Infected Children Living in Central Africa Have Low Persistence of Antibodies to Vaccines Used in the Expanded Program on Immunization
2007

HIV-Infected Children in Central Africa Have Low Antibody Levels to Vaccines

Sample size: 129 publication 10 minutes Evidence: high

Author Information

Author(s): Tejiokem Mathurin C., Gouandjika Ionela, Béniguel Lydie, Zanga Marie-Claire Endegue, Tene Gilbert, Gody Jean C., Njamkepo Elisabeth, Kfutwah Anfumbom, Penda Ida, Bilong Catherine, Rousset Dominique, Pouillot Régis, Tangy Frédéric, Baril Laurence

Primary Institution: Centre Pasteur du Cameroun

Hypothesis

Do HIV-infected children have lower persistence of antibodies to vaccines compared to HIV-exposed uninfected children?

Conclusion

HIV-infected children have significantly lower levels of antibodies to EPI vaccines compared to HIV-exposed uninfected children.

Supporting Evidence

  • Only 20% of children had expected antibody levels against all tested vaccines.
  • HIV-infected children had significantly lower antibody levels to measles compared to uninfected children.
  • The study found a high risk of low antibody levels in HIV-infected children with severe immunodeficiency.

Takeaway

Kids with HIV don't keep their vaccine protection as well as kids without HIV, so they might need extra shots.

Methodology

A cross-sectional study was conducted on children aged 18 to 36 months born to HIV-infected mothers, testing blood samples for antibodies to various vaccines.

Potential Biases

Potential bias due to the exclusion of children with severe health issues and reliance on self-reported vaccination status.

Limitations

The study did not include children with severe clinical status or those recently breastfed, which may limit the generalizability of the findings.

Participant Demographics

Children aged 18 to 36 months, born to HIV-infected mothers, living in Central Africa.

Statistical Information

P-Value

p<0.0001

Confidence Interval

95% CI for GMCs reported

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1371/journal.pone.0001260

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication